ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

Possible Breach of Patient Confidentially By Calif. Physician; NCI

May 6, 1994

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

May 31, 1996

NCI Cooperative Group, Cancer Center Trials Listed

June 27, 2008

Device Maker Threatens Legal Action Against Doctor Who Launched Campaign to End Power Morcellation

September 5, 2014

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978